drugmaker liability News

Investor Suit Alleges Pharma Company Made False Claim of COVID-19 Vaccine

Pennsylvania-based Inovio Pharmaceuticals is the target of a planned class action lawsuit alleging it falsely claimed it has developed a vaccine for COVID-19 that would go into testing as soon as next month. But the pharmaceutical firm has said the …

Judge Cuts Johnson & Johnson Damages in Risperdal Case From $8 Billion to $6.8 Million

A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson to a man who said it failed to warn that boys using its antipsychotic drug Risperdal could grow breasts. Judge …

FDA Moving Quickly to Approve New Drugs. Is It Too Quickly?

The U.S. is approving new drugs so fast that companies are now preparing for a green light months in advance of the scheduled decision date, a pace that’s helping patients with rare or untreatable diseases but raising alarm among consumer …

After Avoiding Ohio Trial, Drug Firms Turn to Local Government Opioid Lawsuits

Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial …

Settling Opioid Suits Probably Won’t End the Crisis: Viewpoint

Imagine you’re the chief executive officer of a large pharmaceutical corporation with an important drug that’s under attack. More than 2,500 lawsuits have been filed against your company. The plaintiffs aren’t individuals, though, they’re governments — counties, cities and states. …

J&J Hit with Year’s Largest Jury Award Over Marketing Risperdal Drug to Teens

Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the U.S. this year — over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized …

Fellow Drugmakers Eye Purdue’s Bankruptcy As Way to Settle Opioid Claims: WSJ

Endo International Plc, Johnson & Johnson and other drugmakers that face litigation over the opioid crisis are exploring a way to settle the cases by participating in Purdue Pharma LP’s bankruptcy, the Wall Street Journal reported, citing internal documents and …

Drug Makers’ Supply Chain Probed as Blood Pressure Pill Tests Positive for Carcinogens

An online pharmacy told U.S. regulators it found another cancer-causing chemical in widely prescribed blood-pressure pills, raising new questions about a complex global web of companies that produces medicine for millions of people. A solvent called dimethylformamide was discovered in …

Lawyers Expect Wave of Litigation Targeting Popular Heart Drugs

Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation. Millions of Americans have taken …

J&J, Bayer Deny Liability But Settle 25,000 Xarelto Lawsuits for $775 Million

Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits alleging that their blockbuster blood thinner Xarelto caused unstoppable and in some cases fatal bleeding for a total of $775 million, court documents on Monday …